Lexicon Pharmaceuticals
LXRX
#6619
Rank
A$0.93 B
Marketcap
A$2.21
Share price
-3.70%
Change (1 day)
271.60%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.27. In 2024 the company made an earnings per share (EPS) of A-$0.91 an increase over its 2023 EPS that were of A-$1.13.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-66.71%
2024A-$0.91-20%
2023A-$1.1331.15%
2022A-$0.87-0%
2021A-$0.8710.91%
2020A-$0.78-145.08%
2019A$1.73-206.09%
2018A-$1.63-5.74%
2017A-$1.73-10.95%
2016A-$1.942640%
2015A-$0.07092-96.34%
2014A-$1.94-2.53%
2013A-$1.99-9.09%
2012A-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.20-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.34-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$61.16-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.42 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.39-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.71 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.06 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.86-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$108.80 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA